Pain/Inflammation Featured Articles

  1. Emerging CROs – One Step Forward And Two Steps Back 4/24/2012

    In discussions with executives in pharma and bio, emerging markets are a hot topic. No longer are emerging markets places where companies can expect to be successful simply by attempting to market products developed in other countries and retrofittedto function in the developing country. By Rob Wright, Chief Editor, Life Science Leader magazine

  2. Insights And A Peek Into The Future For PRO & ePRO 12/12/2011
    PHT Corporation’s U.S. PRO & ePRO Congress, held in Boston Nov. 9-10, shared electronic patient reported outcome (ePRO) adoption growth numbers, discussions of new regulatory guidance, actionable information that can ease site and study subject burden from ePRO, PRO and ePRO in post-approval, and lingering reasons for sponsor reluctance to adopt ePRO. By Sara Gambrill